Key Pharmacology Equations

Why This Matters

Pharmacology equations connect drug properties to clinical decisions. When you're tested on these concepts, you're demonstrating your understanding of pharmacokinetics (what the body does to the drug) and pharmacodynamics (what the drug does to the body). Every equation here answers a practical question: How much drug should you give? How often? How long until it works? Why does this patient need a different dose?

These equations reveal the principles behind drug absorption, distribution, metabolism, and elimination (ADME). You'll see connections between concepts like clearance and half-life, or between volume of distribution and loading dose. Don't just memorize formulas. Know what each variable represents, when you'd use each equation clinically, and how changing one parameter affects the others.

---

Distribution and Dosing Fundamentals

These equations describe how drugs spread through the body and how you calculate initial doses. The key principle: a drug's distribution pattern determines how much you need to give to achieve target concentrations.

Volume of Distribution (Vd)

$V_d = \frac{\text{Dose}}{C_0}$

where $C_0$ is the initial plasma concentration right after IV administration (before any elimination occurs). This is a theoretical volume, not an actual body compartment. It answers the question: "If the drug were evenly distributed at the measured plasma concentration, how large would the container need to be?"

• High $V_d$ values (>40 L, sometimes hundreds of liters) indicate extensive tissue binding or lipophilic drugs that leave the plasma and accumulate in tissues. Chloroquine, for example, has a $V_d$ of roughly 15,000 L because it binds heavily to tissue.
• Low $V_d$ values (~3–5 L) suggest the drug stays primarily in plasma, often due to high protein binding or hydrophilicity. Warfarin stays mostly in plasma bound to albumin, giving it a $V_d$ of about 8 L.

Loading Dose Equation

$\text{Loading Dose} = V_d \times C_{target}$

This is used to rapidly achieve therapeutic concentrations without waiting for steady-state. It's essential for emergencies or drugs with long half-lives where waiting 4–5 half-lives isn't clinically acceptable. You're front-loading the amount needed to fill the entire volume of distribution at once.

If the drug is given orally rather than IV, you need to account for bioavailability:

$\text{Loading Dose (oral)} = \frac{V_d \times C_{target}}{F}$

---

Elimination and Maintenance

These equations govern how drugs leave the body and how you maintain therapeutic levels. The core principle: clearance and half-life determine how often you dose and how much you give to keep levels steady.

Clearance Equation

$CL = \frac{\text{Rate of Elimination}}{C_p}$

or equivalently:

$CL = k_e \times V_d$

Clearance represents the volume of plasma completely cleared of drug per unit time (typically in L/hr or mL/min). Think of it as the body's efficiency at removing the drug.

• Organ-specific clearance includes renal clearance ($CL_R$) and hepatic clearance ($CL_H$). Total systemic clearance is their sum: $CL_{total} = CL_R + CL_H$
• Clinical adjustment is required when renal or hepatic function declines. Reduced clearance means drug accumulates and toxicity risk increases.

Drug Half-Life Equation

$t_{1/2} = \frac{0.693 \times V_d}{CL}$

The 0.693 comes from $\ln(2)$, which reflects first-order elimination kinetics (a constant fraction of drug is eliminated per unit time).

• Determines dosing interval. Most drugs are dosed every 1–2 half-lives to keep plasma concentrations within the therapeutic range.
• Steady-state is reached in 4–5 half-lives regardless of dose size or frequency. At steady-state, drug input equals drug output. After one half-life you're at 50% of steady-state, after two you're at 75%, after three at 87.5%, and so on.

Maintenance Dose Equation

$\text{Maintenance Dose} = CL \times C_{ss} \times \tau$

where $C_{ss}$ is the target steady-state concentration and $\tau$ (tau) is the dosing interval.

For oral dosing, account for bioavailability:

$\text{Maintenance Dose (oral)} = \frac{CL \times C_{ss} \times \tau}{F}$

You're replacing exactly what the body clears between doses. Because the dose is directly proportional to clearance, patients with reduced kidney or liver function need lower maintenance doses (or longer dosing intervals).

---

Absorption and Bioavailability

These equations address how much drug actually reaches systemic circulation. The principle: not all of an administered dose makes it to the bloodstream, and these equations quantify what does.

Bioavailability Equation

$F = \frac{AUC_{oral}}{AUC_{IV}} \times 100\%$

IV administration is the reference standard ($F$ = 100%) since it bypasses all absorption barriers.

• First-pass metabolism is the primary reason oral bioavailability drops. Drugs absorbed from the GI tract travel through the portal vein to the liver before reaching systemic circulation, and the liver can metabolize a large fraction before it ever gets to the rest of the body.
• Formulation matters. Extended-release, enteric-coated, and different salt forms can significantly alter $F$ for the same active ingredient.

Area Under the Curve (AUC)

$AUC = \frac{F \times \text{Dose}}{CL}$

AUC represents total drug exposure over time, measured in concentration × time units (e.g., mg·hr/L). If you plotted plasma concentration on the y-axis and time on the x-axis, AUC is literally the area under that curve.

• Gold standard for bioequivalence. Generic drugs must demonstrate AUC within 80–125% of the brand-name product to gain FDA approval.
• Integrates absorption and elimination. A larger AUC means either more drug absorbed, slower clearance, or both.

---

Ionization and pH Effects

This equation explains how environmental pH affects drug behavior. The principle: most drugs are weak acids or bases, and their ionization state determines absorption, distribution, and excretion.

Henderson-Hasselbalch Equation

For weak acids:

$pH = pK_a + \log\frac{[A^-]}{[HA]}$

The ionized form ($A^-$) is water-soluble but cannot easily cross cell membranes.

For weak bases:

$pH = pK_a + \log\frac{[B]}{[BH^+]}$

The un-ionized form ($B$) is lipid-soluble and crosses membranes readily.

The ion trapping principle follows directly from this: weak acids accumulate in basic environments, and weak bases accumulate in acidic environments. The un-ionized form crosses the membrane, then becomes ionized on the other side and gets "trapped." This is why aspirin overdose is treated with urine alkalinization: making the urine basic traps the aspirin (a weak acid) in its ionized form in the urine, preventing reabsorption.

---

Enzyme Kinetics and Drug Response

These equations describe how drugs interact with biological systems at the molecular level. The principle: drug effects depend on receptor binding and enzyme activity, both of which can be saturated at high concentrations.

Michaelis-Menten Equation

$v = \frac{V_{max} \times [S]}{K_m + [S]}$

This describes reaction velocity ($v$) as a function of substrate concentration ($[S]$).

• $K_m$ (Michaelis constant) equals the substrate concentration at which the reaction runs at half its maximal velocity. A lower $K_m$ means the enzyme has higher affinity for the substrate (it reaches half-max speed at a lower concentration).
• Saturation kinetics are the key concept here. At low $[S]$ (well below $K_m$), the reaction is approximately first-order: doubling the substrate roughly doubles the rate. At high $[S]$ (well above $K_m$), the reaction becomes zero-order: the enzyme is saturated, and adding more substrate doesn't increase the rate.

This matters clinically for drugs like phenytoin and ethanol, which saturate their metabolic enzymes at therapeutic doses. Small dose increases can cause disproportionately large jumps in plasma concentration.

Dose-Response Curve Equation

$E = \frac{E_{max} \times [D]}{EC_{50} + [D]}$

This is mathematically identical to Michaelis-Menten but describes the pharmacodynamic response to a drug.

• $EC_{50}$ defines potency: the drug concentration producing 50% of maximal effect. A lower $EC_{50}$ means a more potent drug (you need less of it).
• $E_{max}$ defines efficacy: the maximum possible response. A full agonist has a higher $E_{max}$ than a partial agonist at the same receptor.

---

Quick Reference Table

---

Self-Check Questions

1. A drug has a very high volume of distribution (500 L). What does this tell you about its tissue binding, and how would this affect your loading dose calculation compared to a drug with $V_d$ of 5 L?

2. Which two equations both use clearance as a key variable, and what different clinical questions do they answer?

3. Compare $K_m$ in the Michaelis-Menten equation to $EC_{50}$ in the dose-response equation. What do both values represent, and what does a lower value indicate in each case?

4. A patient with severe renal impairment needs a drug primarily eliminated by the kidneys. Using the maintenance dose equation, explain why and how you would adjust their dosing regimen.

5. Using the Henderson-Hasselbalch equation, predict whether a weak acid drug ($pK_a$ = 4) would be more ionized in the stomach (pH 2) or the intestine (pH 7). Which location would show better absorption, and why?